The Food and Drug Administration (FDA) recently released its Plant and Animal Biotechnology Innovation Action Plan, which provides an overview of FDA’s efforts to develop a comprehensive policy framework for the oversight of animal biotechnology products, including food and drug products derived from intentionally genetically altered animals and plants.